249 related articles for article (PubMed ID: 31751820)
21. Perineural infiltration as a prognostic factor in surgically treated gallbladder cancer A single center experience and literature review.
Feo CF; Cossu ML; Ginesu GC; Ginesu GC; Fancellu A; Scanu AM; Piras N; Cherchi G; Cossu A; Sotgiu G; Pazzona M; Porcu A
Ann Ital Chir; 2017; 88():485-490. PubMed ID: 29339591
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
[TBL] [Abstract][Full Text] [Related]
23. CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.
Ding Q; Li M; Wu X; Zhang L; Wu W; Ding Q; Weng H; Wang X; Liu Y
Tumour Biol; 2015 Jan; 36(1):193-8. PubMed ID: 25227665
[TBL] [Abstract][Full Text] [Related]
24. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
[TBL] [Abstract][Full Text] [Related]
26. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study.
Fatima N; Srivastava AN; Nigam J; Raza ST; Rizvi S; Siddiqui Z; Kumar V
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1895-1900. PubMed ID: 31244315
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
[TBL] [Abstract][Full Text] [Related]
28. Expression profile and prognostic value of SFN in human ovarian cancer.
Hu Y; Zeng Q; Li C; Xie Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30926680
[TBL] [Abstract][Full Text] [Related]
29. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
30. [Surgical treatment for advanced gallbladder cancer].
Yan L; Zhou Y; Jin L
Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):277-8. PubMed ID: 10374560
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
[TBL] [Abstract][Full Text] [Related]
32. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
35. Intramucosal Extent as a Marker for Advanced Disease and Survival in Gallbladder Adenocarcinoma.
Naples R; Perlmutter BC; Lu H; Allende D; Tu C; Hitawala A; Chadalavada P; Padbidri V; Haddad A; Simon R; Walsh RM; Augustin T
Am Surg; 2024 Jun; 90(6):1133-1139. PubMed ID: 38174690
[TBL] [Abstract][Full Text] [Related]
36. Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Jiang S; Miao XY
Tumour Biol; 2012 Feb; 33(1):173-82. PubMed ID: 22076922
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
38. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
[TBL] [Abstract][Full Text] [Related]
39. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
